Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease

Clinical trial NCT00279825 · COMPLETED

Trial details

NCT number: NCT00279825
Sponsor: Impax Laboratories, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Parkinson's Disease

Start date: 2006-01-01
Primary completion: 2007-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.